Clinical Trial Update: Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study of S-Tenatoprazole-Na (30, 60, 90, 120 mg) in healthy volunteers to characterize dose-related pharmacodynamics and safety. Conduct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease

Drugs mentioned

• S-Tenatoprazole-Na (tenatoprazole sodium)

Snippet

Sponsor: STEBA France | Conditions: Esophagitis, Gastroesophageal Reflux | Phase 1 | Status: COMPLETED